SCHEDULE 13G

RAPT THERAPEUTICS INC

Common Stock, $0.0001 par value per share · CUSIP: 75382E109

Event date: 2024-12-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• BIOTECHNOLOGY VALUE FUND L P

  Shares: 6,046,181.00 · Class: 4.5%

• BVF I GP LLC

  Shares: 6,046,181.00 · Class: 4.5%

• BIOTECHNOLOGY VALUE FUND II LP

  Shares: 4,884,651.00 · Class: 3.7%

• BVF II GP LLC

  Shares: 4,884,651.00 · Class: 3.7%

• Biotechnology Value Trading Fund OS LP

  Shares: 607,975.00 · Class: 0%

• BVF Partners OS Ltd.

  Shares: 607,975.00 · Class: 0%

• BVF GP HOLDINGS LLC

  Shares: 10,930,832.00 · Class: 8.1%

• BVF PARTNERS L P/IL

  Shares: 11,764,000.00 · Class: 8.7%

• BVF INC/IL

  Shares: 11,764,000.00 · Class: 8.7%

• LAMPERT MARK N

  Shares: 11,764,000.00 · Class: 8.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.